DataMeds AI regains Nasdaq equity compliance
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
DataMeds AI, Inc. said it has regained compliance with Nasdaq Listing Rule 5550(b)(1) on minimum stockholders' equity. The company received a deficiency notice on April 13, 2026, after reporting an equity deficit of $(12,447,801) for the fiscal year ended December 31, 2025, below the $2,500,000 requirement. Nasdaq confirmed compliance in writing on October 19, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.